Discovering genomic rearrangements under selection in serious ovarian cancer
发现严重卵巢癌选择下的基因组重排
基本信息
- 批准号:8976219
- 负责人:
- 金额:$ 22.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-01-01 至 2016-12-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAwardBioinformaticsCarcinomaCellsCessation of lifeChromosomal RearrangementClinicalComplexCytogeneticsDNA Sequence RearrangementDataDevelopmentDouble MinutesEarly DiagnosisEarly identificationGene FusionGene RearrangementGenomicsHigh-Throughput Nucleotide SequencingHumanIndividualMalignant NeoplasmsMalignant neoplasm of ovaryMentorsMentorshipMethodsPhaseRNARecurrenceResearch PersonnelSerousStatistical Data InterpretationStatistical MethodsSymptomsTechniquesTechnologyTestingTrainingTranscriptWomananalytical methodcancer genomecareer developmentdeep sequencingdesignkillingsmolecular markernoveloutcome forecastpressureresearch studysuccesstherapeutic targettranscriptometumor
项目摘要
Recurrent gene fusions and internal tandem duplications are among the most tumor-specific molecular
markers known and can provide the potential for therapeutic targets. With a few notable exceptions,
however, relatively common recurrent gene fusions have not been identified in commonly occurring
carcinomas, which often have multiple, complex chromosomal rearrangements that are difficult to analyze by
traditional cytogenetic approaches. Complex tumor karyotpes make it difficult to identify gene fusions using
cytogenetics, but suggest the possibility that recurrent rearrangements producing fusions or internal tandem
duplications (ITDs) may be prevalent. This proposal aims to use deep sequencing and the novel analytic
techniques described to study aspects of the serous ovarian cancer genome and transcriptome which have
remained hidden due to limitations in technology or analytical methods, and to test intra-individual and inter-individual
selective pressures on tumors. The aspects of this proposal are as follows 1) to further investigate
the extent of gene rearrangements in ovarian cancer, focusing on discovering local rearrangements
transcribed into RNA; 2) to determine the composition of a group of novel circular transcripts that I have
recently found to be expressed at relatively high levels in normal and pathogenic human cells; 3) to
characterize double minutes in ovarian cancer, combining bioinformatics to determine rearrangements in
their sequence composition and statistical analysis to determine evolutionary pressures on their composition
exerted by the tumors. The applicant has a track-record of success in discovering novel gene fusions with
ultra-high throughput sequencing (the ESRRA-C11 orf20 fusion), as well as designing original rigorous
statistical and bioinformatic methods for ultra-high throughput data. Under the mentorship of Dr. Patrick O. Brown, a pioneer in high throughput genomic technologies and statistical methods for analyzing them, the applicant will continue career development and training. The first aim of this project will be performed during the mentoring phase, and experiments for aims 2 and 3 will be piloted. The K99/R00 award will support the applicant in her development into an independent investigator.
复发基因融合和内部串联重复是最肿瘤特异性的分子之一
已知的标记,可以提供治疗靶标的潜力。除了一些值得注意的例外,
但是,在通常发生的情况下尚未发现相对常见的复发基因融合
癌通常具有多个复杂的染色体重排,难以通过
传统的细胞遗传学方法。复杂的肿瘤核核使很难识别使用的基因融合
细胞遗传学,但建议复发重排产生融合或内部串联的可能性
重复(ITD)可能很普遍。该建议旨在使用深层测序和新颖的分析
描述的技术是研究浆液卵巢癌基因组和转录组的方面
由于技术或分析方法的局限性,仍隐藏着隐藏,并测试个体内部和个体间
肿瘤的选择性压力。该提案的各个方面如下1)进一步调查
卵巢癌基因重排的程度,重点是发现局部重排
转录为RNA; 2)确定我拥有的一组新型圆形转录本的组成
最近发现在正常和致病性人类细胞中以相对较高的水平表达。 3)到
表征卵巢癌的双分钟,结合生物信息学以确定重排
它们的序列组成和统计分析以确定其组成的进化压力
由肿瘤施加。申请人在发现新颖的基因融合方面拥有成功的轨道纪录
超高吞吐量测序(ESRRA-C11 ORF20融合),并设计原始的严格
超高吞吐量数据的统计和生物信息学方法。在高吞吐量基因组技术和分析统计方法的先驱帕特里克·O·布朗(Patrick O. Brown)的指导下,申请人将继续职业发展和培训。该项目的第一个目标将在指导阶段进行,目标2和3的实验将进行试验。 K99/R00奖将为申请人发展成为独立调查员的发展。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ciRS-7 exonic sequence is embedded in a long non-coding RNA locus.
- DOI:10.1371/journal.pgen.1007114
- 发表时间:2017-12
- 期刊:
- 影响因子:4.5
- 作者:Barrett SP;Parker KR;Horn C;Mata M;Salzman J
- 通讯作者:Salzman J
Cell-type specific features of circular RNA expression.
- DOI:10.1371/journal.pgen.1003777
- 发表时间:2013
- 期刊:
- 影响因子:4.5
- 作者:Salzman J;Chen RE;Olsen MN;Wang PL;Brown PO
- 通讯作者:Brown PO
Circular RNA is expressed across the eukaryotic tree of life.
环状RNA在真核生命树中表达。
- DOI:10.1371/journal.pone.0090859
- 发表时间:2014
- 期刊:
- 影响因子:3.7
- 作者:Wang PL;Bao Y;Yee MC;Barrett SP;Hogan GJ;Olsen MN;Dinneny JR;Brown PO;Salzman J
- 通讯作者:Salzman J
Circular RNA biogenesis can proceed through an exon-containing lariat precursor.
- DOI:10.7554/elife.07540
- 发表时间:2015-06-09
- 期刊:
- 影响因子:7.7
- 作者:Barrett SP;Wang PL;Salzman J
- 通讯作者:Salzman J
Circular RNA Expression: Its Potential Regulation and Function.
- DOI:10.1016/j.tig.2016.03.002
- 发表时间:2016-05
- 期刊:
- 影响因子:0
- 作者:Salzman J
- 通讯作者:Salzman J
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julia Salzman其他文献
Julia Salzman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julia Salzman', 18)}}的其他基金
Computational- and experimental- driven discovery of splicing regulation and circRNA function
计算和实验驱动的剪接调控和 circRNA 功能发现
- 批准号:
10321906 - 财政年份:2021
- 资助金额:
$ 22.78万 - 项目类别:
AI/ML Ready appraoches for integrative RNA processing, splicing and spatial genomics
用于整合 RNA 处理、剪接和空间基因组学的 AI/ML Ready 方法
- 批准号:
10407768 - 财政年份:2021
- 资助金额:
$ 22.78万 - 项目类别:
Computational- and experimental- driven discovery of splicing regulation and circRNA function
计算和实验驱动的剪接调控和 circRNA 功能发现
- 批准号:
10565918 - 财政年份:2021
- 资助金额:
$ 22.78万 - 项目类别:
Unbiased discovery of mechanisms regulating circRNA
circRNA调节机制的公正发现
- 批准号:
9332410 - 财政年份:2015
- 资助金额:
$ 22.78万 - 项目类别:
Discovering genomic rearrangements under selection in serious ovarian cancer
发现严重卵巢癌选择下的基因组重排
- 批准号:
8773658 - 财政年份:2014
- 资助金额:
$ 22.78万 - 项目类别:
Discovering genomic rearrangements under selection in serious ovarian cancer
发现严重卵巢癌选择下的基因组重排
- 批准号:
8788508 - 财政年份:2014
- 资助金额:
$ 22.78万 - 项目类别:
Discovering genomic rearrangements under selection in serious ovarian cancer
发现严重卵巢癌选择下的基因组重排
- 批准号:
8354071 - 财政年份:2012
- 资助金额:
$ 22.78万 - 项目类别:
相似国自然基金
生态补奖背景下草原牧户实现自主性减畜的机制、路径和政策研究
- 批准号:72374130
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
草原生态补奖政策对牧户兼业行为的影响机理研究——以内蒙古为例
- 批准号:72363025
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
草原生态补奖政策对牧民调整草场经营行为的影响研究:作用机理、实证分析与政策优化
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
草原生态补奖政策对牧民调整草场经营行为的影响研究:作用机理、实证分析与政策优化
- 批准号:72104063
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
草原生态补奖政策激励-约束下牧民生产行为决策机制及生态效应
- 批准号:
- 批准年份:2020
- 资助金额:50 万元
- 项目类别:
相似海外基金
Mentoring the next generation of substance use, HIV, and epigenetic researchers in sexual and gender minority health
指导下一代性和性别少数健康领域的药物滥用、艾滋病毒和表观遗传学研究人员
- 批准号:
10699933 - 财政年份:2023
- 资助金额:
$ 22.78万 - 项目类别:
O-GlcNAcylation and YAP: Defining a novel pathway in heart failure
O-GlcNAcylation 和 YAP:定义心力衰竭的新途径
- 批准号:
10685543 - 财政年份:2022
- 资助金额:
$ 22.78万 - 项目类别:
O-GlcNAcylation and YAP: Defining a novel pathway in heart failure
O-GlcNAcylation 和 YAP:定义心力衰竭的新途径
- 批准号:
10507138 - 财政年份:2022
- 资助金额:
$ 22.78万 - 项目类别:
Mechanism Guided Therapy for Laryngopharyngeal Reflux
机制引导治疗咽喉反流
- 批准号:
10212755 - 财政年份:2021
- 资助金额:
$ 22.78万 - 项目类别:
Identifying genetic sources of comorbidity between cannabis and schizophrenia using genome-wide and integrative omics data
使用全基因组和综合组学数据识别大麻和精神分裂症之间共病的遗传来源
- 批准号:
10594423 - 财政年份:2021
- 资助金额:
$ 22.78万 - 项目类别: